ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 26 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $126,953 | -20.4% | 19,005 | 0.0% | 0.00% | – |
Q2 2023 | $159,452 | +59.5% | 19,005 | -15.5% | 0.00% | – |
Q1 2022 | $99,977 | -9.9% | 22,492 | -18.6% | 0.00% | – |
Q4 2021 | $111,000 | -53.4% | 27,645 | +2.2% | 0.00% | – |
Q3 2021 | $238,000 | -25.6% | 27,061 | -4.2% | 0.00% | – |
Q2 2021 | $320,000 | +259.6% | 28,251 | +84.8% | 0.00% | – |
Q4 2019 | $89,000 | -8.2% | 15,284 | -9.5% | 0.00% | – |
Q3 2019 | $97,000 | -4.0% | 16,887 | 0.0% | 0.00% | – |
Q2 2019 | $101,000 | +10000.0% | 16,887 | +12048.9% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 139 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -91.7% | 139 | -91.4% | 0.00% | – |
Q3 2017 | $12,000 | +200.0% | 1,612 | +85.3% | 0.00% | – |
Q2 2017 | $4,000 | -20.0% | 870 | -7.5% | 0.00% | – |
Q1 2017 | $5,000 | 0.0% | 941 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -28.6% | 941 | 0.0% | 0.00% | – |
Q3 2016 | $7,000 | +40.0% | 941 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | +25.0% | 941 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | +100.0% | 941 | +158.5% | 0.00% | – |
Q3 2014 | $2,000 | – | 364 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |